Patents by Inventor Eric Denarier

Eric Denarier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230404973
    Abstract: The invention concerns a compound of formula (I), Formula (I), R, R1 and R2 are independently selected form the group consisting of: —a hydrogen atom, —a halogen atom, —an alkyl group, linear, cyclic or branched, saturated or unsaturated, possibly substituted, comprising from 1 to 10 carbon atoms, —an acyl group comprising from 1 to 10 carbon atoms, —a carboxyl group, —an amido group comprising from 1 to 10 carbon atoms, and —an imino group, possibly substituted by an alkyl group, linear, cyclic or branched, saturated or unsaturated, and wherein R3, R4, R5 and R6 are independently selected form the group consisting of: —a hydrogen atom, —a halogen atom, —a hydroxyl group, —an alkyl group, linear, cyclic or branched, saturated or unsaturated, possibly substituted, comprising from 1 to 10 carbon atoms, —an alkoxy group comprising from 1 to 10 carbon atoms, —an acyl group comprising from 1 to 10 carbon atoms, —a carbonate group from 1 to 10 carbon atoms, —a carboxyl group, and —a cyano group.
    Type: Application
    Filed: October 12, 2020
    Publication date: December 21, 2023
    Inventors: Laurence LAFANECHÈRE, Renaud PRUDENT, Lauralie PERONNE, Marc BILLAUD, Audrey VERNET, Eric DENARIER, Patrick DALLEMAGNE, Sylvain RAULT, Peggy SUZANNE, Jean-charles LANCELOT, Serge PERATO, Aurélien LESNARD
  • Patent number: 8198507
    Abstract: The invention concerns transgenic or recombinant non-human mammals, wherein the expression of the gene coding for a microtubule associated protein (MAP) is modified (STOP gene) (inactivation or overexpression) and their uses in screening medicines useful in schizophrenia and schizo-affective disorders, with anxious, paranoiac or depressive component.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: June 12, 2012
    Assignees: Institut National de la Sante Et de la Recherche Medicale - INSERM, Commissariat a l'Energie Atomique Et Aux Energies Alternatives
    Inventors: Annie Andrieux, Didier Job, Eric Denarier, Christophe Bosc, Muriel Vernet
  • Publication number: 20090064353
    Abstract: The invention concerns transgenic or recombinant non-human mammals, wherein the expression of the gene coding for a microtubule associated protein (MAP) is modified (STOP gene) (inactivation or overexpression) and their uses in screening medicines useful in schizophrenia and schizo-affective disorders, with anxious, paranoiac or depressive component.
    Type: Application
    Filed: May 14, 2007
    Publication date: March 5, 2009
    Inventors: Annie Andrieux, Didier Job, Eric Denarier, Christophe Bosc, Muriel Vernet
  • Publication number: 20040093625
    Abstract: The invention concerns transgenic or recombinant non-human mammals, wherein the expression of the gene coding for a microtubule associated protein (MAP) is modified (STOP gene) (inactivation or overexpression) and their uses in screening medicines useful in schizophrenia and schizo-affective disorders, with anxious, paranoiac or depressive component.
    Type: Application
    Filed: November 17, 2003
    Publication date: May 13, 2004
    Inventors: Annie Andrieux, Didier Job, Eric Denarier, Christophe Bosc, Muriel Vernet